GM-CSF / IL3 fusion protein

重组人粒细胞-巨噬细胞集落刺激因子和白细胞介素3融合蛋白

Report date: 2023/08/29 20:00:52

Base Information

Drug NameGM-CSF / IL3 fusion protein
Drug Alias NameMX fusion proteinMX融合蛋白
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin 3 receptor agonistsColony stimulating factor 3 receptor agonists
TargetsInterleukin 3 receptorColony stimulating factor 3 receptor
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Zhao'An Medical Technology Co LtdBeijing Igus Medical Technology Development Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSun Yat-Sen University
Inactive CompaniesBeijing Igus Medical Technology Development Co LtdShanghai Zhao'An Medical Technology Co Ltd
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A